I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ramchandren, Radhakrishnan
81
results:
Search for persons
X
Format
Online (81)
Mediatypes
Articles (Online) (34)
OpenAccess-fulltext (47)
Sorted by: Relevance
Sorted by: Year
?
1
The iR2 regimen (ibrutinib plus lenalidomide and rituximab)..:
Ramchandren, Radhakrishnan
;
Johnson, Peter
;
Ghosh, Nilanjan
...
eClinicalMedicine. 56 (2023) - p. 101779 , 2023
Link:
https://doi.org/10.1016/..
?
2
Editorial: Advances in the treatment of Hodgkin lymphoma:
Mei, Matthew
;
Perini, Guilherme
;
Ramchandren, Radhakrishnan
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
Quality-of-life analysis of pembrolizumab vs brentuximab ve..:
Zinzani, Pier Luigi
;
Ramchandren, Radhakrishnan
;
Santoro, Armando
...
Blood Advances. 6 (2022) 2 - p. 590-599 , 2022
Link:
https://doi.org/10.1182/..
?
4
P009: Improved Overall Survival with First-Line Brentuximab..:
Hutchings, Martin
;
Ansell, Stephen M.
;
Connors, Joseph M.
...
HemaSphere. 6 (2022) - p. 4-5 , 2022
Link:
https://doi.org/10.1097/..
?
5
HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Imp..:
Straus, David
;
Radford, John
;
Connors, Joseph
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S350 , 2022
Link:
https://doi.org/10.1016/..
?
6
CTIM-34. PRELIMINARY SAFETY AND EFFICACY DATA ON TWO PATIEN..:
Iqbal, Madiha
;
Tun, Han
;
Joffe, Erel
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii68-vii69 , 2022
Link:
https://doi.org/10.1093/..
?
7
Outcomes Among Classical Hodgkin Lymphoma Patients After an..:
Hamid, Muhammad Saad
;
Rutherford, Sarah C.
;
Jang, Hyejeong
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 7 - p. e435-e442 , 2022
Link:
https://doi.org/10.1016/..
?
8
Poster: HL-507 First-Line Brentuximab Vedotin Plus Chemothe..:
Straus, David
;
Radford, John
;
Connors, Joseph
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S161 , 2022
Link:
https://doi.org/10.1016/..
?
9
Autologous stem cell transplantation after anti-PD-1 therap..:
Merryman, Reid W.
;
Redd, Robert A.
;
Nishihori, Taiga
...
Blood Advances. 5 (2021) 6 - p. 1648-1659 , 2021
Link:
https://doi.org/10.1182/..
?
10
HL-147: Brentuximab Vedotin with Chemotherapy for Patients ..:
Ramchandren, Radhakrishnan
;
Dfugosz-Danecka, Monika
;
Connors, Joseph M.
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S371 , 2021
Link:
https://doi.org/10.1016/..
?
11
Fimepinostat (CUDC‐907) in patients with relapsed/refractor..:
Landsburg, Daniel J.
;
Barta, Stefan K.
;
Ramchandren, Radhakrishnan
...
British Journal of Haematology. 195 (2021) 2 - p. 201-209 , 2021
Link:
https://doi.org/10.1111/..
?
12
Concurrent ibrutinib plus venetoclax in relapsed/refractory..:
Wang, Michael
;
Ramchandren, Radhakrishnan
;
Chen, Robert
...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
13
Poster: HL-147: Brentuximab Vedotin with Chemotherapy for P..:
Ramchandren, Radhakrishnan
;
Długosz-Danecka, Monika
;
Connors, Joseph M.
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S236 , 2021
Link:
https://doi.org/10.1016/..
?
14
Urelumab alone or in combination with rituximab in patients..:
Timmerman, John
;
Herbaux, Charles
;
Ribrag, Vincent
...
American Journal of Hematology. 95 (2020) 5 - p. 510-520 , 2020
Link:
https://doi.org/10.1002/..
?
15
Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphom..:
Carreau, Nicole A.
;
Pail, Orrin
;
Armand, Philippe
...
The Oncologist. 25 (2020) 10 - p. 878-885 , 2020
Link:
https://doi.org/10.1634/..
1-15